DHAKA, Aug. 12 (Xinhua) — China’s contributions through the COVAX Facility have reflected Beijing’s commitment to global anti-COVID-19 fight, Bangladesh health experts said.<\/p>\n\n\n\n
They expressed appreciation of China’s contributions after Bangladesh Tuesday night received 1.7 million Chinese COVID-19 vaccine doses shipped via the COVAX Facility.<\/p>\n\n\n\n
This is the first among three consignments that are scheduled to arrive in Bangladesh from China this week.<\/p>\n\n\n\n
With their remarks, the Bangladeshi experts joined the distinguished persons around the world who had expressed admiration to the Chinese leadership’s efforts in promoting international cooperation in the fight against COVID-19 and making vaccines a global public good.<\/p>\n\n\n\n
China has recently pledged to provide 2 billion COVID-19 vaccine doses to the world throughout this year and offer 100 million U.S. dollars to COVAX.<\/p>\n\n\n\n
Muzaherul Huq, former Southeast Asia Region adviser at the World Health Organization (WHO), said Wednesday this is a great initiative and will be much appreciated by the people of poverty-stricken countries who can not afford to purchase the vaccine for their people.<\/p>\n\n\n\n
“The COVAX participation of China with its 2 vaccines will be a great contribution,” said the expert.<\/p>\n\n\n\n
Also, he said China has already supplied vaccines to people of many countries and regions around the world.<\/p>\n\n\n\n
While some rich countries are playing vaccine diplomacy in a period when the world is in a crisis, “China is proving that they want to help poorer countries in this crisis to save human lives,” said the expert.<\/p>\n\n\n\n
M Mushtuq Husain, adviser to the Institute of Epidemiology, Disease Control and Research (IEDCR) under Bangladesh’s Ministry of Health and Family Welfare, said Chinese vaccine contributions would surely boost Bangladeshi efforts in the country’s nationwide ongoing mass inoculation drive.<\/p>\n\n\n\n
“Every vaccine is very important for us. We’re very happy that China sent many vaccine doses for Bangladesh through COVAX Facility,” he said.<\/p>\n\n\n\n
The Bangladeshi health official said people across Bangladesh are gladly receiving the Chinese COVID-19 vaccine doses. <\/p>\n\n\n\n
Source: http:\/\/www.xinhuanet.com\/english\/2021-08\/12\/c_1310123685.htm <\/p>","protected":false},"excerpt":{"rendered":"
DHAKA, Aug. 12 (Xinhua) — China’s contributions through the COVAX Facility have reflected Beijing’s commitment to global anti-COVID-19 fight, Bangladesh health experts said. They expressed appreciation of China’s contributions after Bangladesh Tuesday night received 1.7 million Chinese COVID-19 vaccine doses shipped via the COVAX Facility. This is the first among […]<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_themeisle_gutenberg_block_has_review":false,"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_newsletter_tier_id":0,"jetpack_publicize_message":"","jetpack_is_tweetstorm":false,"jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false}}},"categories":[28],"tags":[],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":2190,"url":"https:\/\/www.govisachina.com\/zh\/2021\/05\/10\/who-approval-of-sinopharm-vaccine-set-to-benefit-world-coronavirus-fight\/","url_meta":{"origin":2449,"position":0},"title":"WHO approval of Sinopharm vaccine set to benefit world coronavirus fight","author":"Visa China","date":"5\u6708 10, 2021","format":false,"excerpt":"By BO LEUNG in London The World Health Organization's approval to give emergency use to the COVID-19 vaccine manufactured by China's Sinopharm has been welcomed by experts and health regulators worldwide. On Friday, the WHO gave the vaccine the green light, paving the way for potentially millions of doses to\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2314,"url":"https:\/\/www.govisachina.com\/zh\/2021\/06\/02\/who-validates-chinas-sinovac-covid-19-vaccine-for-emergency-use\/","url_meta":{"origin":2449,"position":1},"title":"WHO validates China’s Sinovac COVID-19 vaccine for emergency use","author":"Visa China","date":"6\u6708 2, 2021","format":false,"excerpt":"GENEVA, June 1 (Xinhua) The World Health Organization (WHO) validated on Tuesday the CoronaVac COVID-19 vaccine developed by Chinese pharmaceutical company Sinovac for emergency use. \"I am happy to announce that the Sinovac coronavirus vaccine has been given WHO Emergency Use Listing (EUL) after being found to be safe, effective,\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":2417,"url":"https:\/\/www.govisachina.com\/zh\/2021\/07\/28\/chinese-doses-help-address-covid-19-vaccine-divide-in-timely-manner-expert\/","url_meta":{"origin":2449,"position":2},"title":"Chinese doses help address COVID-19 vaccine divide in timely manner: expert","author":"Visa China","date":"7\u6708 28, 2021","format":false,"excerpt":"NEW YORK, July 26 (Xinhua) -- COVAX, the global COVID-19 vaccine equity scheme, has agreed to buy 110 million Chinese doses of Sinovac and Sinopharm, thus gaining immediate access to lifesaving vaccines that are proved to be safe and effective, a vaccine expert has said. Such a decision by COVAX\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2439,"url":"https:\/\/www.govisachina.com\/zh\/2021\/08\/06\/xinhua-headlines-china-is-keeping-its-word-in-building-global-immunity-barrier\/","url_meta":{"origin":2449,"position":3},"title":"Xinhua Headlines: China is keeping its word in building global immunity barrier","author":"Visa China","date":"8\u6708 6, 2021","format":false,"excerpt":"BEIJING, Aug. 5 (Xinhua) -- China will strive to provide 2 billion COVID-19 vaccine doses to the world throughout this year and offer 100 million U.S. dollars to COVAX, Chinese President Xi Jinping said here Thursday, marking a further step by China in honoring its commitment to making vaccines a\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2401,"url":"https:\/\/www.govisachina.com\/zh\/2021\/07\/13\/providing-500-mln-vaccine-doses-to-world-china-aims-to-enhance-intl-cooperation-against-covid-19\/","url_meta":{"origin":2449,"position":4},"title":"Providing 500 mln vaccine doses to world, China aims to enhance int’l cooperation against COVID-19","author":"Visa China","date":"7\u6708 13, 2021","format":false,"excerpt":"BEIJING, July 13 (Xinhua) -- Chinese vaccines are gathering steam across the world, injecting strong impetus into the global fight against COVID-19 as deaths from the virus topped 4 million worldwide and variants spread to more than 100 countries. As a steadfast advocate for equitable vaccine distribution around the globe,\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2202,"url":"https:\/\/www.govisachina.com\/zh\/2021\/05\/17\/chinas-sinopharm-covid-19-vaccine-likely-conducive-to-global-vaccine-accessibility-indian-newspaper\/","url_meta":{"origin":2449,"position":5},"title":"China’s Sinopharm COVID-19 vaccine likely conducive to global vaccine accessibility: Indian newspaper","author":"Visa China","date":"5\u6708 17, 2021","format":false,"excerpt":"Xinhua\u00a0 NEW DELHI - China's Sinopharm COVID-19 vaccine, the first non-Western vaccine supported by the World Health Organization (WHO), is likely to be used in the COVAX program, which provides vaccines to low- and middle-income countries, reported the Indian Express newspaper Thursday. The WHO last week validated the China-developed vaccine\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/posts\/2449"}],"collection":[{"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/comments?post=2449"}],"version-history":[{"count":1,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/posts\/2449\/revisions"}],"predecessor-version":[{"id":2450,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/posts\/2449\/revisions\/2450"}],"wp:attachment":[{"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/media?parent=2449"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/categories?post=2449"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/tags?post=2449"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}